National Cancer Institute's (NCI) analysis of COVID-19 IgG/IgM Rapid Test Cassette Reported 100% Combined Sensitivity, and 97.5% Combined Specificity for the Lateral Flow Immunoassay ENGLEWOOD, CO / ...
The COVID-19 pandemic, which was caused by SARS-CoV-2, has had a significant effect on global public health, economies, and societies worldwide. Serum antibody testing is a critical method for the ...
Announcing a new article publication for Zoonoses journal. The COVID-19 pandemic, which was caused by SARS-CoV-2, has had a significant effect on global public health, economies, and societies ...
The analysis included results from 2 tests that have received EUA: the SARS-CoV-2 ELISA test (Euroimmun) and the COVID-19 IgG/IgM Rapid Test Cassette (Healgen). The Food and Drug Administration (FDA) ...
BAC BV, the Bio Affinity Company, announced the addition of two new products to its CaptureSelect® Antibody Toolbox. The new products, affinity matrices for the purification of IgA and IgM, address a ...
Josh Disbrow, Chief Executive Officer of Aytu BioScience, commented, "This independently-conducted study by the National Cancer Institute further establishes the clinical validity of this rapid test ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results